FDA approves first claudin-18.2-targeted antibody for gastric cancer

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2024年 / 23卷 / 12期
关键词：
D O I：
10.1038/d41573-024-00172-7
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 50 条
  • [31] FDA approves monoclonal antibody for metastatic breast cancer
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (11): : 1557 - 1557
  • [32] DEVELOPMENT OF CLAUDIN 18.2 TAC T CELLS FOR THE TREATMENT OF GASTRIC CANCER
    Helsen, Christopher
    Benatar, Tania
    Philbert, I. P.
    Xu, Stacey
    Shaver, Laura
    Nitya-Nootan, Thanyashanthi
    Bader, Andreas
    Lal, Prabha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A127 - A127
  • [33] Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
    Jianwei Zhang
    Ruilan Dong
    Lin Shen
    ChineseJournalofCancerResearch, 2020, 32 (02) : 263 - 270
  • [34] Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer
    Kubota, Yohei
    Shitara, Kohei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [35] Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer
    Baek, Jin Ho
    Park, Dong Jin
    Kim, Gyu Yeol
    Cheon, Jaekyung
    Kang, Byung Woog
    Cha, Hee Jeong
    Kim, Jong Gwang
    ANTICANCER RESEARCH, 2019, 39 (12) : 6973 - 6979
  • [36] Expression of claudin 18.2 in peritoneal metastasis (PM) of gastric cancer.
    Saito, Akira
    Ohzawa, Hideyuki
    Matsumiya, Misaki
    Takahashi, Rei
    Tamura, Kohei
    Kaneko, Yuki
    Futoh, Yurie
    Kawashima, Rie
    Miyato, Hideyo
    Sata, Naohiro
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 403 - 403
  • [37] FDA approves first EGFR exon 20 targeted kinase inhibitor
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) : 806 - 806
  • [38] FDA approves first EGFR exon 20 targeted kinase inhibitor
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 806 - 806
  • [39] High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.
    Tureci, Ozlem
    Itoh, Kyogo
    Yamaguchi, Rin
    Mukhina, Svetlana
    Sahin, Ugur
    Rohde, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Correlation of Claudin18.2 expression with clinicopathological characteristics and prognosis in gastric cancer
    Tao, Daoyu
    Guan, Bingxin
    Li, Zengxian
    Jiao, Meng
    Zhou, Chengjun
    Li, Hui
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
12345